Transfusion-Related Acute Lung Injury
"Transfusion-Related Acute Lung Injury" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rare but serious transfusion-related reaction in which fluid builds up in the lungs unrelated to excessively high infusion rate and/or volume (TRANSFUSION-ASSOCIATED CIRCULATORY OVERLOAD). Signs of Transfusion-Related Acute Lung Injury include pulmonary secretions; hypotension; fever; DYSPNEA; TACHYPNEA; TACHYCARDIA; and CYANOSIS.
Descriptor ID |
D000073617
|
MeSH Number(s) |
C08.381.520.500.500 C15.378.962.500 C20.920.500
|
Concept/Terms |
Transfusion-Related Acute Lung Injury- Transfusion-Related Acute Lung Injury
- Transfusion Related Acute Lung Injury
- Acute Lung Injury, Transfusion-Related
- Acute Lung Injury, Transfusion Related
- TRALI
|
Below are MeSH descriptors whose meaning is more general than "Transfusion-Related Acute Lung Injury".
Below are MeSH descriptors whose meaning is more specific than "Transfusion-Related Acute Lung Injury".
This graph shows the total number of publications written about "Transfusion-Related Acute Lung Injury" by people in this website by year, and whether "Transfusion-Related Acute Lung Injury" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2020 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transfusion-Related Acute Lung Injury" by people in Profiles.
-
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol. 2021 07; 18(7):435-453.
-
Elevated Rate of HLA Antibodies in Male COVID-19 Convalescent Plasma Donors: A Risk Factor for Transfusion-Related Acute Lung Injury. Mayo Clin Proc. 2021 02; 96(2):500-502.